Literature DB >> 626489

Comparative nephrotoxicity of gentamicin and tobramycin in rats.

D N Gilbert, C Plamp, P Starr, W M Bennet, D C Houghton, G Porter.   

Abstract

A rat model was utilized to compare the nephrotoxic potential of gentamicin and tobramycin. Gentamicin, 40 mg/kg per day, predictably produced renal failure and morphological evidence of proximal tubular necrosis over 14 days of treatment. An identical dosage of tobramycin was associated with only minimal morphological changes and normal concentrations of serum creatinine and blood urea nitrogen. Similar results were obtained even after the tobramycin dosage was tripled to 120 mg/kg per day. A decrease in urine osmolality, mechanism unknown, was observed in all aminoglycoside-treated rats, but the lowest osmolalities were found in the gentamicin-treated rats. According to both histological criteria and renal function measurements, gentamicin was more nephrotoxic than tobramycin in this animal model.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 626489      PMCID: PMC352181          DOI: 10.1128/AAC.13.1.34

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  The determination of endogenous creatinine in plasma and urine.

Authors:  H N HAUGEN
Journal:  Scand J Clin Lab Invest       Date:  1953       Impact factor: 1.713

2.  Comparative in vitro activity of Sch 20656, netilmicin, gentamicin, and tobramycin.

Authors:  C Watanakunakorn
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

Review 3.  Tobramycin: an overview.

Authors:  H C Neu
Journal:  J Infect Dis       Date:  1976-08       Impact factor: 5.226

4.  A comparative study of the ototoxicity of tobramycin and gentamicin.

Authors:  R E Brummett; D Himes; B Saine; J Vernon
Journal:  Arch Otolaryngol       Date:  1972-12

5.  In vitro comparison of four aminoglycoside antibiotics: sisomicin, gentamicin, tobramycin, and BB-K8.

Authors:  M E Levison; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

6.  Controlled comparison of amikacin and gentamicin.

Authors:  C R Smith; K L Baughman; C Q Edwards; J F Rogers; P S Lietman
Journal:  N Engl J Med       Date:  1977-02-17       Impact factor: 91.245

7.  Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae.

Authors:  D J Briedis; H G Robson
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

Review 8.  Aspects of the pharmacology and toxicology of tobramycin in animals and humans.

Authors:  K S Israel; J S Welles; H R Black
Journal:  J Infect Dis       Date:  1976-08       Impact factor: 5.226

9.  The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.

Authors:  E S REYNOLDS
Journal:  J Cell Biol       Date:  1963-04       Impact factor: 10.539

10.  Improvements in epoxy resin embedding methods.

Authors:  J H LUFT
Journal:  J Biophys Biochem Cytol       Date:  1961-02
View more
  17 in total

1.  Influence of single or multiple doses of gentamicin and netilmicin on their cortical, medullary, and papillary distribution.

Authors:  M G Bergeron; S Trottier
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

2.  Relationship between rat renal accumulation of gentamicin, tobramycin, and netilmicin and their nephrotoxicities.

Authors:  M E Brier; P R Mayer; R A Brier; D Visscher; F C Luft; G R Aronoff
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

3.  Antibacterial activities, nephrotoxicity, and ototoxicity of a new aminoglycoside, Win 42122-2.

Authors:  P E Came; J R O'Connor; R A Dobson; R B Wagner; R J Fabian
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

4.  Comparative nephrotoxicities of high-dose netilmicin and tobramycin in rats.

Authors:  R A Parker; D N Gilbert; D C Houghton; G A Porter; W M Bennett
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

5.  Gentamicin, netilmicin, dibekacin, and amikacin nephrotoxicity and its relationship to tubular reabsorption in rabbits.

Authors:  N Brion; J Barge; I Godefroy; F Dromer; C Dubois; A Contrepois; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

6.  Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients.

Authors:  J J Schentag; M E Plaut; F B Cerra
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

Review 7.  [Tobramycin concentrations in human renal tissue (author's transl)].

Authors:  O Brückner; U Kroening; R Nagel
Journal:  Infection       Date:  1979       Impact factor: 3.553

8.  Temporal changes of pharmacokinetics, nephrotoxicity, and subcellular distribution of tobramycin in rats.

Authors:  L Lin; L Grenier; Y Bergeron; M Simard; M G Bergeron; G Labrecque; D Beauchamp
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

9.  Effects of polyaspartic acid on pharmacokinetics of tobramycin in two strains of rat.

Authors:  M K Reinhard; I Bekersky; T W Sanders; B J Harris; G H Hottendorf
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

10.  Aminoglycoside accumulation kinetics in rat renal parenchyma.

Authors:  G R Aronoff; S T Pottratz; M E Brier; N E Walker; N S Fineberg; M D Glant; F C Luft
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.